25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

COCP (Cocrystal Pharma Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Cocrystal Pharma Inc together

I guess you are interested in Cocrystal Pharma Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Cocrystal Pharma Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Cocrystal Pharma Inc’s Price Targets

I'm going to help you getting a better view of Cocrystal Pharma Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Cocrystal Pharma Inc

I send you an email if I find something interesting about Cocrystal Pharma Inc.

1. Quick Overview

1.1. Quick analysis of Cocrystal Pharma Inc (30 sec.)










1.2. What can you expect buying and holding a share of Cocrystal Pharma Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.91
Expected worth in 1 year
$-0.40
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$-1.31
Return On Investment
-86.3%

For what price can you sell your share?

Current Price per Share
$1.52
Expected price per share
$1.4 - $1.6915
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cocrystal Pharma Inc (5 min.)




Live pricePrice per Share (EOD)
$1.52
Intrinsic Value Per Share
$-14.55 - $-4.61
Total Value Per Share
$-13.64 - $-3.70

2.2. Growth of Cocrystal Pharma Inc (5 min.)




Is Cocrystal Pharma Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$9.2m$28.5m-$16.3m-134.1%

How much money is Cocrystal Pharma Inc making?

Current yearPrevious yearGrowGrow %
Making money-$3.9m-$4.1m$225.5k5.7%
Net Profit Margin0.0%-775.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Cocrystal Pharma Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#598 / 881

Most Revenue
#671 / 881

Most Profit
#377 / 881

Most Efficient
#375 / 881
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cocrystal Pharma Inc?

Welcome investor! Cocrystal Pharma Inc's management wants to use your money to grow the business. In return you get a share of Cocrystal Pharma Inc.

First you should know what it really means to hold a share of Cocrystal Pharma Inc. And how you can make/lose money.

Speculation

The Price per Share of Cocrystal Pharma Inc is $1.52. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cocrystal Pharma Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cocrystal Pharma Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.91. Based on the TTM, the Book Value Change Per Share is $-0.33 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.30 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cocrystal Pharma Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.23-14.9%-0.39-25.6%-0.41-27.1%-0.58-38.5%-0.48-31.5%-0.75-49.1%
Usd Book Value Change Per Share-0.03-1.9%-0.33-21.6%-0.30-19.5%-0.53-34.7%-0.15-10.1%-0.44-29.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.03-1.9%-0.33-21.6%-0.30-19.5%-0.53-34.7%-0.15-10.1%-0.44-29.0%
Usd Price Per Share1.42-1.88-1.85-1.63-1.41-1.45-
Price to Earnings Ratio-1.57--1.29--1.12--1.01--1.00--1.33-
Price-to-Total Gains Ratio-50.16--16.25-464.46-148.62-87.40-42.41-
Price to Book Ratio1.56-1.62-0.65-0.86-0.60-0.41-
Price-to-Total Gains Ratio-50.16--16.25-464.46-148.62-87.40-42.41-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.52
Number of shares657
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.33-0.15
Usd Total Gains Per Share-0.33-0.15
Gains per Quarter (657 shares)-215.52-100.73
Gains per Year (657 shares)-862.09-402.92
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-862-8720-403-413
20-1724-17340-806-816
30-2586-25960-1209-1219
40-3448-34580-1612-1622
50-4310-43200-2015-2025
60-5173-51820-2417-2428
70-6035-60440-2820-2831
80-6897-69060-3223-3234
90-7759-77680-3626-3637
100-8621-86300-4029-4040

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%2.038.00.05.0%3.067.00.04.3%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%4.016.00.020.0%13.027.00.032.5%20.048.02.028.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%1.00.069.01.4%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%4.016.00.020.0%13.027.00.032.5%20.048.02.028.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Cocrystal Pharma Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.028-0.328+1059%-0.297+949%-0.527+1762%-0.153+442%-0.441+1458%
Book Value Per Share--0.9081.200-24%2.810-68%2.709-66%4.125-78%7.488-88%
Current Ratio--4.5716.017-24%14.621-69%14.459-68%19.710-77%11.500-60%
Debt To Asset Ratio--0.1340.209-36%0.102+31%0.121+10%0.088+52%0.119+12%
Debt To Equity Ratio--0.1950.282-31%0.117+66%0.152+29%0.107+82%0.148+32%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--19944080.00027871055.000-28%43293912.700-54%40576456.383-51%45856373.354-57%22585544.173-12%
Eps---0.226-0.389+72%-0.412+82%-0.585+159%-0.479+112%-0.746+230%
Ev To Ebitda Ratio---2.130-1.842-13%-2.317+9%-2.316+9%-3.182+49%-1.445-32%
Free Cash Flow Per Share---0.289-0.367+27%-0.385+33%-0.421+46%-0.373+29%-0.2890%
Free Cash Flow To Equity Per Share---0.289-0.367+27%-0.387+34%-0.421+46%-0.090-69%0.094-408%
Gross Profit Margin--1.0001.0020%1.0020%1.0010%1.0010%1.0000%
Intrinsic Value_10Y_max---4.607----------
Intrinsic Value_10Y_min---14.547----------
Intrinsic Value_1Y_max---1.056----------
Intrinsic Value_1Y_min---1.655----------
Intrinsic Value_3Y_max---2.720----------
Intrinsic Value_3Y_min---4.831----------
Intrinsic Value_5Y_max---3.838----------
Intrinsic Value_5Y_min---7.828----------
Market Cap15464176.000+7%14447080.00019152555.000-25%18776412.700-23%16577706.383-13%14372023.354+1%16559019.173-13%
Net Profit Margin----0%-7.7500%-2.5830%-36.5040%-17.0880%
Operating Margin----0%-4.7990%-1.6000%-35.9150%-16.1850%
Operating Ratio----0%9.962-100%3.321-100%39.490-100%15.369-100%
Pb Ratio1.675+7%1.5641.624-4%0.654+139%0.862+81%0.597+162%0.412+280%
Pe Ratio-1.680-7%-1.570-1.290-18%-1.121-29%-1.011-36%-1.001-36%-1.327-15%
Price Per Share1.520+7%1.4201.883-25%1.846-23%1.629-13%1.413+1%1.449-2%
Price To Free Cash Flow Ratio-1.315-7%-1.229-1.333+8%-1.289+5%-1.122-9%-1.097-11%-1.585+29%
Price To Total Gains Ratio-53.696-7%-50.163-16.252-68%464.458-111%148.617-134%87.403-157%42.412-218%
Quick Ratio--3.5845.601-36%13.727-74%13.640-74%19.116-81%11.158-68%
Return On Assets---0.216-0.253+17%-0.134-38%-0.232+7%-0.159-26%-0.158-27%
Return On Equity---0.315-0.339+7%-0.150-52%-0.272-14%-0.185-41%-0.180-43%
Total Gains Per Share---0.028-0.328+1059%-0.297+949%-0.527+1762%-0.153+442%-0.441+1458%
Usd Book Value--9235000.00012212750.000-24%28585250.000-68%27560833.333-66%41970700.000-78%77292775.000-88%
Usd Book Value Change Per Share---0.028-0.328+1059%-0.297+949%-0.527+1762%-0.153+442%-0.441+1458%
Usd Book Value Per Share--0.9081.200-24%2.810-68%2.709-66%4.125-78%7.488-88%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--19944080.00027871055.000-28%43293912.700-54%40576456.383-51%45856373.354-57%22585544.173-12%
Usd Eps---0.226-0.389+72%-0.412+82%-0.585+159%-0.479+112%-0.746+230%
Usd Free Cash Flow---2939000.000-3730250.000+27%-3919080.663+33%-4279360.221+46%-3791116.133+29%-2970758.066+1%
Usd Free Cash Flow Per Share---0.289-0.367+27%-0.385+33%-0.421+46%-0.373+29%-0.2890%
Usd Free Cash Flow To Equity Per Share---0.289-0.367+27%-0.387+34%-0.421+46%-0.090-69%0.094-408%
Usd Market Cap15464176.000+7%14447080.00019152555.000-25%18776412.700-23%16577706.383-13%14372023.354+1%16559019.173-13%
Usd Price Per Share1.520+7%1.4201.883-25%1.846-23%1.629-13%1.413+1%1.449-2%
Usd Profit---2301000.000-3962250.000+72%-4187750.000+82%-7766333.333+238%-5962500.000+159%-8188150.000+256%
Usd Revenue----0%36000.000-100%12000.000-100%110621.350-100%253060.675-100%
Usd Total Gains Per Share---0.028-0.328+1059%-0.297+949%-0.527+1762%-0.153+442%-0.441+1458%
 EOD+5 -3MRQTTM+19 -14YOY+16 -193Y+18 -175Y+17 -1810Y+11 -24

3.3 Fundamental Score

Let's check the fundamental score of Cocrystal Pharma Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.680
Price to Book Ratio (EOD)Between0-11.675
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.584
Current Ratio (MRQ)Greater than14.571
Debt to Asset Ratio (MRQ)Less than10.134
Debt to Equity Ratio (MRQ)Less than10.195
Return on Equity (MRQ)Greater than0.15-0.315
Return on Assets (MRQ)Greater than0.05-0.216
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Cocrystal Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.635
Ma 20Greater thanMa 501.551
Ma 50Greater thanMa 1001.540
Ma 100Greater thanMa 2001.571
OpenGreater thanClose1.480
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Cocrystal Pharma Inc

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases in the United States. It employs structure-based technologies to create antiviral drugs including influenza virus, coronaviruses, such as SARS-CoV-2 and MERS-CoV, as well as norovirus, respiratory virus infections, and hepatitis C virus (HCV) infections. The company develops CC-42344, a novel PB2 inhibitor, which is in phase 2a clinical trial, as a potential treatment for pandemic and seasonal influenza A; and the inhaled CC-42344 for the potential prophylactic treatment of pandemic and seasonal influenza infections. It is also developing CDI-988, an oral pan-viral, which is phase 1 clinical trial to treat noroviruses and coronaviruses, including SARS-CoV-2 and its variants; and CC-31244, a HCV non-nucleoside inhibitor that has completed Phase 2a clinical trial to treat HCV. The company has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. Cocrystal Pharma, Inc. was founded in 2006 and is based in Bothell, Washington.

Fundamental data was last updated by Penke on 2025-06-19 02:55:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Cocrystal Pharma Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Cocrystal Pharma Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cocrystal Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-775.0%+775.0%
TTM-5Y-3,650.4%+3,650.4%
5Y-3,650.4%10Y-1,708.8%-1,941.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--91.7%+91.7%
TTM--139.0%+139.0%
YOY-775.0%-194.4%-580.6%
3Y-258.3%-248.5%-9.8%
5Y-3,650.4%-343.3%-3,307.1%
10Y-1,708.8%-488.9%-1,219.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Cocrystal Pharma Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Cocrystal Pharma Inc to theΒ Biotechnology industry mean.
  • -21.6% Return on Assets means thatΒ Cocrystal Pharma Inc generatedΒ $-0.22 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cocrystal Pharma Inc:

  • The MRQ is -21.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -25.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-21.6%TTM-25.3%+3.7%
TTM-25.3%YOY-13.4%-11.9%
TTM-25.3%5Y-15.9%-9.3%
5Y-15.9%10Y-15.8%-0.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-21.6%-11.6%-10.0%
TTM-25.3%-11.7%-13.6%
YOY-13.4%-11.4%-2.0%
3Y-23.2%-11.9%-11.3%
5Y-15.9%-12.0%-3.9%
10Y-15.8%-13.8%-2.0%
4.3.1.3. Return on Equity

Shows how efficient Cocrystal Pharma Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Cocrystal Pharma Inc to theΒ Biotechnology industry mean.
  • -31.5% Return on Equity means Cocrystal Pharma Inc generated $-0.32Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cocrystal Pharma Inc:

  • The MRQ is -31.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -33.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-31.5%TTM-33.9%+2.3%
TTM-33.9%YOY-15.0%-18.8%
TTM-33.9%5Y-18.5%-15.4%
5Y-18.5%10Y-18.0%-0.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-31.5%-13.5%-18.0%
TTM-33.9%-15.0%-18.9%
YOY-15.0%-14.5%-0.5%
3Y-27.2%-16.9%-10.3%
5Y-18.5%-17.7%-0.8%
10Y-18.0%-19.9%+1.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Cocrystal Pharma Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Cocrystal Pharma Inc is operatingΒ .

  • Measures how much profit Cocrystal Pharma Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Cocrystal Pharma Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cocrystal Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-479.9%+479.9%
TTM-5Y-3,591.5%+3,591.5%
5Y-3,591.5%10Y-1,618.5%-1,973.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.5%+232.5%
TTM--250.3%+250.3%
YOY-479.9%-208.4%-271.5%
3Y-160.0%-221.7%+61.7%
5Y-3,591.5%-344.1%-3,247.4%
10Y-1,618.5%-470.4%-1,148.1%
4.3.2.2. Operating Ratio

Measures how efficient Cocrystal Pharma Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cocrystal Pharma Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY9.962-9.962
TTM-5Y39.490-39.490
5Y39.49010Y15.369+24.121
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.108-2.108
TTM-2.680-2.680
YOY9.9623.080+6.882
3Y3.3213.621-0.300
5Y39.4904.734+34.756
10Y15.3696.546+8.823
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Cocrystal Pharma Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cocrystal Pharma Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 4.57Β means the company has $4.57 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cocrystal Pharma Inc:

  • The MRQ is 4.571. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.017. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.571TTM6.017-1.446
TTM6.017YOY14.621-8.605
TTM6.0175Y19.710-13.693
5Y19.71010Y11.500+8.210
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.5713.616+0.955
TTM6.0173.826+2.191
YOY14.6214.141+10.480
3Y14.4594.661+9.798
5Y19.7105.756+13.954
10Y11.5006.149+5.351
4.4.3.2. Quick Ratio

Measures if Cocrystal Pharma Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Cocrystal Pharma Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 3.58Β means the company can pay off $3.58 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cocrystal Pharma Inc:

  • The MRQ is 3.584. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.601. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.584TTM5.601-2.017
TTM5.601YOY13.727-8.126
TTM5.6015Y19.116-13.514
5Y19.11610Y11.158+7.957
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5842.799+0.785
TTM5.6013.143+2.458
YOY13.7273.794+9.933
3Y13.6404.307+9.333
5Y19.1165.707+13.409
10Y11.1586.457+4.701
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Cocrystal Pharma Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Cocrystal Pharma IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Cocrystal Pharma Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.13Β means that Cocrystal Pharma Inc assets areΒ financed with 13.4% credit (debt) and the remaining percentage (100% - 13.4%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Cocrystal Pharma Inc:

  • The MRQ is 0.134. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.209. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.134TTM0.209-0.076
TTM0.209YOY0.102+0.107
TTM0.2095Y0.088+0.121
5Y0.08810Y0.119-0.031
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1340.327-0.193
TTM0.2090.348-0.139
YOY0.1020.327-0.225
3Y0.1210.340-0.219
5Y0.0880.349-0.261
10Y0.1190.379-0.260
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Cocrystal Pharma Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Cocrystal Pharma Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 19.5% means that company has $0.19 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cocrystal Pharma Inc:

  • The MRQ is 0.195. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.282. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.195TTM0.282-0.087
TTM0.282YOY0.117+0.164
TTM0.2825Y0.107+0.175
5Y0.10710Y0.148-0.041
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1950.379-0.184
TTM0.2820.435-0.153
YOY0.1170.412-0.295
3Y0.1520.448-0.296
5Y0.1070.460-0.353
10Y0.1480.509-0.361
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Cocrystal Pharma Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Cocrystal Pharma Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -1.57 means the investor is paying $-1.57Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cocrystal Pharma Inc:

  • The EOD is -1.680. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.570. Based on the earnings, the company is expensive. -2
  • The TTM is -1.290. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.680MRQ-1.570-0.111
MRQ-1.570TTM-1.290-0.280
TTM-1.290YOY-1.121-0.169
TTM-1.2905Y-1.001-0.289
5Y-1.00110Y-1.327+0.326
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.680-2.303+0.623
MRQ-1.570-2.062+0.492
TTM-1.290-2.541+1.251
YOY-1.121-3.741+2.620
3Y-1.011-3.754+2.743
5Y-1.001-6.136+5.135
10Y-1.327-6.686+5.359
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cocrystal Pharma Inc:

  • The EOD is -1.315. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.229. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.333. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.315MRQ-1.229-0.087
MRQ-1.229TTM-1.333+0.104
TTM-1.333YOY-1.289-0.044
TTM-1.3335Y-1.097-0.236
5Y-1.09710Y-1.585+0.489
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.315-3.178+1.863
MRQ-1.229-2.700+1.471
TTM-1.333-3.619+2.286
YOY-1.289-4.357+3.068
3Y-1.122-5.065+3.943
5Y-1.097-8.478+7.381
10Y-1.585-9.275+7.690
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Cocrystal Pharma Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 1.56 means the investor is paying $1.56Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cocrystal Pharma Inc:

  • The EOD is 1.675. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.564. Based on the equity, the company is underpriced. +1
  • The TTM is 1.624. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.675MRQ1.564+0.110
MRQ1.564TTM1.624-0.059
TTM1.624YOY0.654+0.970
TTM1.6245Y0.597+1.027
5Y0.59710Y0.412+0.185
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.6751.963-0.288
MRQ1.5641.848-0.284
TTM1.6242.119-0.495
YOY0.6542.469-1.815
3Y0.8622.526-1.664
5Y0.5973.664-3.067
10Y0.4124.351-3.939
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Cocrystal Pharma Inc.

4.8.1. Institutions holding Cocrystal Pharma Inc

Institutions are holding 7.36% of the shares of Cocrystal Pharma Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Vanguard Group Inc2.7095027565600
2025-03-31Renaissance Technologies Corp1.23480.0003125628-200-0.1589
2025-03-31BlackRock Inc0.724907374600
2025-03-31Geode Capital Management, LLC0.718707311942296.1388
2025-03-31Neuberger Berman Group LLC0.58260.000159271592710
2025-03-31Susquehanna International Group, LLP0.331103368321556177.7521
2025-03-31State Street Corp0.201902054300
2025-03-31Parallel Advisors, LLC0.14970.00051522800
2025-03-31Dimensional Fund Advisors, Inc.0.1435014596-419-2.7905
2025-03-31Northern Trust Corp0.1172011921-250-2.0541
2025-03-31Citadel Advisors Llc0.0986010034100340
2025-03-31Bank of America Corp0.08870902210.0111
2024-12-31UBS Group AG0.0603061305220573.6264
2025-03-31Morgan Stanley - Brokerage Accounts0.057605863-58483-90.8883
2025-03-31Tower Research Capital LLC0.01920.000119571127135.7831
2025-03-31Northwestern Mutual Wealth Management Co0.008081700
2025-03-31Clean Yield Group Inc0.00410.000241800
2025-03-31Mccormack Advisors International0.0023023700
2025-03-31JPMorgan Chase & Co0.0010104-155-59.8456
2025-03-31NVWM, LLC0.000808400
Total 7.25450.0012738057+41931+5.7%

4.9.2. Funds holding Cocrystal Pharma Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Vanguard Total Stock Mkt Idx Inv1.8809019135900
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr0.75410.00017672100
2025-04-30Fidelity Extended Market Index0.3890.000239579-379-0.9485
2025-04-30Fidelity Series Total Market Index0.09460962900
2025-04-30DFA US Targeted Value I0.09320.0001948700
2025-04-30Fidelity Total Market Index0.08380852600
2024-12-31Vanguard Instl Ttl Stck Mkt Idx Tr0.07450.0001757600
2025-04-30Vanguard Instl Ttl Stk Mkt Idx InstlPls0.07450757600
2025-04-30Spartan Extended Market Index Pool F0.06470.000165813796.1109
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.06080.0002618200
2025-04-30Fidelity Nasdaq Composite Index0.06020.00016122-731-10.6669
2025-03-31NT Ext Equity Mkt Idx Fd - L0.05260.0001535100
2025-03-31Northern Trust Extended Eq Market Idx0.05260.0001535100
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.04730.00024812-88-1.7959
2025-05-30Dimensional US Targeted Value ETF0.04530.0001460500
2025-03-31BNYM Mellon SL Market Completion UC10.02820.00092870-10-0.3472
2025-04-30Spartan Total Market Index Pool G0.02670271980441.9843
2025-05-31State St US Extended Mkt Indx NL Cl C0.02520.0002256700
2025-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.01260.00011285100.7843
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.01250.0001127512750
Total 3.93330.0027400173+1260+0.3%

5.3. Insider Transactions

Insiders are holding 36.35% of the shares of Cocrystal Pharma Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-04-04Phillip Md Et Al FrostBUY10152291.97
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets10,659
Total Liabilities1,424
Total Stockholder Equity7,304
 As reported
Total Liabilities 1,424
Total Stockholder Equity+ 7,304
Total Assets = 10,659

Assets

Total Assets10,659
Total Current Assets8,826
Long-term Assets1,833
Total Current Assets
Cash And Cash Equivalents 6,921
Other Current Assets 1,905
Total Current Assets  (as reported)8,826
Total Current Assets  (calculated)8,826
+/-0
Long-term Assets
Property Plant Equipment 1,747
Long-term Assets Other 86
Long-term Assets  (as reported)1,833
Long-term Assets  (calculated)1,833
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,931
Long-term Liabilities1,424
Total Stockholder Equity7,304
Total Current Liabilities
Short-term Debt 309
Accounts payable 808
Other Current Liabilities 1,622
Total Current Liabilities  (as reported)1,931
Total Current Liabilities  (calculated)2,739
+/- 808
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,424
Long-term Liabilities  (as reported)1,424
Long-term Liabilities  (calculated)1,424
+/-0
Total Stockholder Equity
Common Stock10
Retained Earnings -335,719
Other Stockholders Equity 343,013
Total Stockholder Equity (as reported)7,304
Total Stockholder Equity (calculated)7,304
+/-0
Other
Capital Stock10
Cash and Short Term Investments 6,921
Common Stock Shares Outstanding 10,174
Liabilities and Stockholders Equity 10,659
Net Debt -5,188
Net Invested Capital 7,304
Net Working Capital 6,895
Property Plant and Equipment Gross 3,702
Short Long Term Debt Total 1,733



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-30
> Total Assets 
-5
171
162
148
142
137
125
121
117
113
105
94
91
89
2,337
11,120
10,706
7,547
7,547
9,071
8,260
7,240
7,113
7,701
7,597
6,456
6,456
12,967
11,635
259,283
268,603
269,129
266,160
224,230
225,168
220,148
220,901
124,883
122,518
124,340
122,253
121,426
120,721
126,325
124,171
68,562
76,291
74,907
73,437
28,531
42,841
40,478
53,216
54,242
53,851
87,417
82,598
79,392
75,372
52,383
45,647
40,840
37,841
36,279
32,614
31,259
26,546
21,573
16,233
13,456
10,659
10,65913,45616,23321,57326,54631,25932,61436,27937,84140,84045,64752,38375,37279,39282,59887,41753,85154,24253,21640,47842,84128,53173,43774,90776,29168,562124,171126,325120,721121,426122,253124,340122,518124,883220,901220,148225,168224,230266,160269,129268,603259,28311,63512,9676,4566,4567,5977,7017,1137,2408,2609,0717,5477,54710,70611,1202,337899194105113117121125137142148162171-5
   > Total Current Assets 
-5
110
100
85
80
75
63
54
50
46
38
28
25
23
2,122
6,444
6,056
2,904
2,904
4,369
3,644
2,670
2,523
3,235
2,826
6,456
6,456
10,097
5,803
6,376
15,754
16,329
13,225
9,919
10,916
5,936
6,755
5,472
3,100
4,941
2,879
2,176
1,481
7,099
4,991
2,943
9,868
8,533
7,013
8,281
22,582
20,102
32,899
34,015
33,691
67,337
62,441
59,323
55,399
51,596
44,896
40,178
37,236
35,761
32,205
29,091
24,492
19,660
14,256
11,580
8,826
8,82611,58014,25619,66024,49229,09132,20535,76137,23640,17844,89651,59655,39959,32362,44167,33733,69134,01532,89920,10222,5828,2817,0138,5339,8682,9434,9917,0991,4812,1762,8794,9413,1005,4726,7555,93610,9169,91913,22516,32915,7546,3765,80310,0976,4566,4562,8263,2352,5232,6703,6444,3692,9042,9046,0566,4442,1222325283846505463758085100110-5
       Cash And Cash Equivalents 
-1
110
95
85
79
75
62
49
46
43
36
27
25
23
2,122
1,840
782
416
416
174
83
62
92
354
530
589
589
4,074
3,006
3,970
14,257
15,781
12,413
9,276
10,242
5,022
5,906
3,640
1,555
3,451
1,345
748
1,249
6,841
4,684
2,723
8,571
7,474
5,994
7,418
21,686
19,315
31,781
33,010
33,278
67,062
61,644
58,705
54,789
51,033
42,056
37,144
33,981
32,419
29,738
26,428
21,917
18,143
13,020
9,860
6,921
6,9219,86013,02018,14321,91726,42829,73832,41933,98137,14442,05651,03354,78958,70561,64467,06233,27833,01031,78119,31521,6867,4185,9947,4748,5712,7234,6846,8411,2497481,3453,4511,5553,6405,9065,02210,2429,27612,41315,78114,2573,9703,0064,0745895895303549262831744164167821,8402,122232527364346496275798595110-1
       Short-term Investments 
-4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
0
0
0
7,285
5,719
2,500
1,975
993
0
0
0
0
0
0
0
0
0
0
29
29
29
29
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000002929292900000000009931,9752,5005,7197,2850009000000000000000000000-4
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,397
0
1,671
1,826
523
523
1,261
920
835
563
1,153
362
139
0
148
181
287
312
184
180
202
188
226
224
1,315
1,294
1,294
1,294
1,295
1,295
0
0
0
1,078
914
768
644
644
592
581
556
556
0
0
0
0
0
0
716
956
1,207
550
890
1,003
1,077
652
1,215
0
01,2156521,0771,0038905501,2079567160000005565565815926446447689141,0780001,2951,2951,2941,2941,2941,31522422618820218018431228718114801393621,1535638359201,2615235231,8261,67101,3970000000000000
       Other Current Assets 
0
0
5
0
0
1
1
5
4
0
1
1
0
-3,899
0
94
60
0
145
562
490
0
189
203
208
5,867
139
156
116
144
192
364
632
441
486
688
1,250
517
251
196
480
104
203
258
307
220
219
145
251
219
252
195
537
449
413
275
797
618
610
563
2,840
2,318
2,224
2,135
1,917
1,848
1,647
440
1,745
505
1,905
1,9055051,7454401,6471,8481,9172,1352,2242,3182,8405636106187972754134495371952522192511452192203072582031044801962515171,2506884864416323641921441161561395,8672082031890490562145060940-3,8990110451100500
   > Long-term Assets 
0
61
62
62
62
62
62
67
67
0
67
67
67
67
214
4,677
4,650
0
4,642
4,703
4,616
0
4,591
4,466
4,771
3,692
3,692
2,870
5,832
252,907
252,849
252,800
252,935
214,311
214,252
214,212
214,146
119,411
119,418
119,399
119,374
119,250
119,240
119,226
119,180
65,619
66,423
66,374
66,424
20,250
20,259
20,376
20,317
20,227
20,160
20,080
20,157
20,069
19,973
787
751
662
605
518
409
2,168
2,054
1,913
1,977
1,876
1,833
1,8331,8761,9771,9132,0542,16840951860566275178719,97320,06920,15720,08020,16020,22720,31720,37620,25920,25066,42466,37466,42365,619119,180119,226119,240119,250119,374119,399119,418119,411214,146214,212214,252214,311252,935252,800252,849252,9075,8322,8703,6923,6924,7714,4664,59104,6164,7034,64204,6504,67721467676767067676262626262610
       Property Plant Equipment 
0
0
1
1
1
1
1
6
6
6
6
5
5
5
5
3,139
3,187
3,342
3,342
3,410
3,344
3,334
3,371
3,263
3,133
2,531
2,531
361
314
284
245
215
369
430
392
357
320
280
287
268
243
119
109
95
31
384
1,188
1,129
1,179
1,108
1,128
1,249
1,179
1,089
1,022
942
1,019
931
835
741
705
616
559
472
363
2,122
2,008
1,884
1,948
1,847
1,747
1,7471,8471,9481,8842,0082,1223634725596167057418359311,0199421,0221,0891,1791,2491,1281,1081,1791,1291,18838431951091192432682872803203573924303692152452843143612,5312,5313,1333,2633,3713,3343,3443,4103,3423,3423,1873,139555566661111100
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,299
1,354
1,027
1,027
1,027
1,027
1,027
1,027
1,027
1,027
1,027
1,027
0
0
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
65,195
19,092
19,092
19,092
19,092
19,092
19,092
19,092
19,092
19,092
19,092
0
0
0
0
0
0
0
0
0
0
0
0
00000000000019,09219,09219,09219,09219,09219,09219,09219,09219,09219,09265,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,19565,195001,0271,0271,0271,0271,0271,0271,0271,0271,0271,0271,3541,299000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,496
2,431
2,412
2,393
2,374
2,354
2,333
2,303
2,276
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000002,2762,3032,3332,3542,3742,3932,4122,4315,4960000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
247
247
219
205
191
177
163
148
134
134
0
0
184,966
184,966
184,966
184,966
146,301
146,301
146,301
146,301
53,905
53,905
53,905
53,905
53,905
53,905
53,905
53,905
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000053,90553,90553,90553,90553,90553,90553,90553,905146,301146,301146,301146,301184,966184,966184,966184,9660013413414816317719120521924724700000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-3,692
-3,692
0
5,518
252,623
252,604
252,585
252,566
213,881
213,860
213,855
213,826
119,131
119,131
119,131
119,131
119,131
0
53,936
53,954
40
40
50
50
50
39
35
590
544
46
46
46
46
46
0
46
0
0
46
0
0
0
0
0
0
0
0000000460046046464646465445903539505050404053,95453,9360119,131119,131119,131119,131119,131213,826213,855213,860213,881252,566252,585252,604252,6235,5180-3,692-3,6920000000000000000000000000
> Total Liabilities 
0
24
36
36
38
42
46
50
52
58
53
63
76
82
2,334
10,754
10,883
10,316
10,316
13,003
8,335
10,820
12,169
13,010
18,051
12,482
12,482
6,911
7,657
252,632
79,905
72,606
69,407
56,636
55,825
53,315
53,079
22,564
22,535
22,304
22,255
16,026
16,585
13,679
13,270
1,674
2,471
2,489
2,692
2,823
2,410
3,423
3,039
1,737
1,793
2,669
1,586
1,843
1,792
2,990
1,738
1,273
3,172
1,597
1,924
4,875
3,961
4,183
3,530
3,933
1,424
1,4243,9333,5304,1833,9614,8751,9241,5973,1721,2731,7382,9901,7921,8431,5862,6691,7931,7373,0393,4232,4102,8232,6922,4892,4711,67413,27013,67916,58516,02622,25522,30422,53522,56453,07953,31555,82556,63669,40772,60679,905252,6327,6576,91112,48212,48218,05113,01012,16910,8208,33513,00310,31610,31610,88310,7542,334827663535852504642383636240
   > Total Current Liabilities 
0
24
36
36
38
42
46
50
52
58
53
63
76
82
2,334
7,543
7,796
7,278
7,278
10,049
5,421
7,926
9,213
10,108
15,287
12,482
12,482
6,911
7,657
9,157
14,648
7,349
4,151
6,700
5,891
3,383
3,150
2,039
2,026
1,800
1,756
1,406
1,358
1,053
1,137
1,557
1,753
1,854
2,105
2,286
1,925
2,943
2,614
1,358
1,457
2,379
1,228
1,545
1,558
2,813
1,619
1,216
3,145
1,587
1,924
3,262
2,379
2,654
1,948
2,428
1,931
1,9312,4281,9482,6542,3793,2621,9241,5873,1451,2161,6192,8131,5581,5451,2282,3791,4571,3582,6142,9431,9252,2862,1051,8541,7531,5571,1371,0531,3581,4061,7561,8002,0262,0393,1503,3835,8916,7004,1517,34914,6489,1577,6576,91112,48212,48215,28710,1089,2137,9265,42110,0497,2787,2787,7967,5432,334827663535852504642383636240
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
3,883
0
5,741
4,134
261
3,410
2,576
1,422
1,654
3,122
3,493
2,421
156
12,089
6,450
7,242
8,464
13,456
6,130
3,096
4,115
2,807
1,869
1,907
1,476
905
707
855
569
548
288
159
477
758
740
650
560
464
452
456
434
406
380
466
472
486
484
482
480
208
332
236
480
240
502
293
602
309
3096022935022404802363322084804824844864724663804064344564524645606507407584771592885485698557079051,4761,9071,8692,8074,1153,0966,13013,4568,4647,2426,45012,0891562,4213,4933,1221,6541,4222,5763,4102614,1345,74103,8830000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,464
0
0
0
4,115
0
1,869
1,907
1,476
905
707
855
1,007
2,039
0
0
0
161
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000001610002,0391,0078557079051,4761,9071,86904,1150008,46400000000000000000000000000000
       Accounts payable 
0
24
36
36
38
0
0
0
0
0
0
0
0
964
82
1,435
2,725
0
1,617
1,608
1,019
0
1,467
1,462
209
255
224
180
125
693
737
838
724
2,585
3,084
1,514
1,243
563
1,121
1,093
901
837
810
765
978
1,077
441
1,071
1,092
1,511
922
832
1,485
657
748
939
491
578
858
616
897
614
2,654
1,041
568
1,222
1,234
1,743
859
1,542
808
8081,5428591,7431,2341,2225681,0412,6546148976168585784919397486571,4858329221,5111,0921,0714411,0779787658108379011,0931,1215631,2431,5143,0842,5857248387376931251802242552091,4621,46701,0191,6081,61702,7251,4358296400000000383636240
       Other Current Liabilities 
0
0
0
0
0
42
46
50
52
0
53
63
76
-4,764
2,252
366
936
0
2,251
5,865
2,980
0
4,624
5,153
12,657
11,969
12,258
6,731
7,532
8,464
13,911
6,511
3,427
4,115
2,807
1,869
1,907
1,476
905
707
855
569
548
288
159
3
554
43
363
215
539
1,659
673
267
303
1,060
271
495
214
1,713
240
122
283
214
1,120
1,560
905
409
796
585
1,622
1,6225857964099051,5601,1202142831222401,7132144952711,0603032676731,6595392153634355431592885485698557079051,4761,9071,8692,8074,1153,4276,51113,9118,4647,5326,73112,25811,96912,6575,1534,62402,9805,8652,25109363662,252-4,76476635305250464200000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
3,044
0
3,211
3,087
0
3,038
2,954
2,913
0
2,957
2,901
2,764
2,711
2,711
0
0
243,475
65,257
65,257
65,256
49,936
49,934
49,932
49,929
20,525
20,509
20,504
20,499
14,620
15,227
12,626
12,133
117
718
635
587
537
485
480
425
379
336
290
358
298
234
177
119
57
27
10
0
1,613
1,582
1,529
1,582
1,505
1,424
1,4241,5051,5821,5291,5821,613010275711917723429835829033637942548048553758763571811712,13312,62615,22714,62020,49920,50420,50920,52549,92949,93249,93449,93665,25665,25765,257243,475002,7112,7112,7642,9012,95702,9132,9543,03803,0873,21103,0440000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,211
3,087
0
0
0
0
0
0
0
0
0
0
0
0
65,257
0
0
0
49,936
0
0
0
0
0
0
0
1,007
2,039
0
0
117
61
21
18
14
10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000001014182161117002,0391,007000000049,93600065,2570000000000003,0873,211000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
62
62
62
61
61
59
57
54
63
47
42
37
31
13,188
12,626
12,133
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000012,13312,62613,1883137424763545759616162626200000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
184,966
65,257
65,257
65,256
146,301
49,934
49,932
49,929
20,525
20,509
20,504
20,499
13,613
13,188
12,626
12,133
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000012,13312,62613,18813,61320,49920,50420,50920,52549,92949,93249,934146,30165,25665,25765,257184,96600000000000000000000000000000
> Total Stockholder Equity
192
148
127
113
105
97
80
73
67
0
54
34
19
10
6
366
-178
0
-2,769
-3,932
-75
0
-5,056
-5,309
-10,455
-6,026
-6,026
6,056
3,978
6,651
188,698
196,523
196,753
167,594
169,343
166,833
167,822
102,319
99,983
102,036
99,998
105,400
104,136
112,646
110,901
66,888
73,820
72,418
70,745
25,708
40,431
37,055
50,177
52,505
52,058
84,748
81,012
77,549
73,580
49,393
43,909
39,567
34,669
34,682
30,690
26,384
22,585
17,390
12,703
9,523
7,304
7,3049,52312,70317,39022,58526,38430,69034,68234,66939,56743,90949,39373,58077,54981,01284,74852,05852,50550,17737,05540,43125,70870,74572,41873,82066,888110,901112,646104,136105,40099,998102,03699,983102,319167,822166,833169,343167,594196,753196,523188,6986,6513,9786,056-6,026-6,026-10,455-5,309-5,0560-75-3,932-2,7690-178366610193454067738097105113127148192
   Common Stock
192
4
4
4
4
4
4
4
4
0
4
4
4
4
38
67
68
0
55
62
63
0
63
69
70
114
114
122
123
123
687
694
694
694
704
704
714
714
714
727
728
24
24
30
30
30
32
32
32
36
53
53
69
71
72
98
98
98
98
98
8
8
8
10
10
10
10
10
10
10
10
101010101010101088898989898987271695353363232323030302424728727714714714704704694694694687123123122114114706963063625506867384444044444444192
   Retained Earnings -335,719-333,418-330,152-325,213-319,870-315,914-311,450-307,285-303,119-297,930-293,429-287,729-263,301-259,093-255,408-251,467-247,646-244,908-243,415-240,745-237,250-235,260-187,415-185,635-184,120-187,091-142,805-140,940-139,596-138,043-143,240-140,981-139,978-137,430-71,676-69,795-66,568-62,556-32,107-31,599-28,976-12,434-10,527-7,978-33,750-33,750-21,658-16,350-15,604-14,128-10,623-17,412-6,163-6,163-4,373-2,033-209-204-196-180-159-156-145-139-132-114-106-97-83-620
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
-1
-1
-1
-1
-1
-1
0
-4,224
-4,307
-4,558
-4,558
-4,765
-4,871
-4,929
-5,042
0
-5,280
-10
-10
1,827
2,235
236
-744
0
0
-1,153
0
0
0
-1,354
-1,354
0
0
-1,358
-1,358
0
0
-983
-1,006
-1,028
-1,053
-1,081
-1,111
-1,056
-1,102
0
-1,159
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000-1,1590-1,102-1,056-1,111-1,081-1,053-1,028-1,006-98300-1,358-1,35800-1,354-1,354000-1,15300-7442362,2351,827-10-10-5,2800-5,042-4,929-4,871-4,765-4,558-4,558-4,307-4,2240-1-1-1-1-1-100000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,332
4,128
0
0
0
0
0
0
0
0
27,610
11,961
12,084
12,146
18,725
217,731
227,428
228,166
229,456
235,207
235,924
238,784
239,035
239,247
242,290
242,510
243,419
243,708
253,556
253,676
253,949
257,908
258,021
258,128
260,932
277,628
277,747
293,523
297,342
299,632
336,117
0
0
0
0
0
0
0
341,957
0
0
0
0
0
0
0
0000000341,9570000000336,117299,632297,342293,523277,747277,628260,932258,128258,021257,908253,949253,676253,556243,708243,419242,510242,290239,247239,035238,784235,924235,207229,456228,166227,428217,73118,72512,14612,08411,96127,610000000004,1282,332000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000000000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-17,878
Operating Income-17,878-17,878
 
Operating Expense (+$)
Research Development12,537
Selling General Administrative5,341
Selling And Marketing Expenses0
Operating Expense17,87817,878
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-537
Net Interest Income537
 
Pretax Income (+$)
Operating Income-17,878
Net Interest Income537
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-17,504-18,252
EBIT - interestExpense = -17,878
-35,008
-17,504
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-17,878-17,504
Earnings Before Interest and Taxes (EBITDA)-17,432
 
After tax Income (+$)
Income Before Tax-17,504
Tax Provision-0
Net Income From Continuing Ops-17,504-17,504
Net Income-17,504
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses17,878
Total Other Income/Expenses Net374-537
 

Technical Analysis of Cocrystal Pharma Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cocrystal Pharma Inc. The general trend of Cocrystal Pharma Inc is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cocrystal Pharma Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Cocrystal Pharma Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cocrystal Pharma Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.63 < 1.68 < 1.6915.

The bearish price targets are: 1.45 > 1.4 > 1.4.

Know someone who trades $COCP? Share this with them.πŸ‘‡

Cocrystal Pharma Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cocrystal Pharma Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cocrystal Pharma Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cocrystal Pharma Inc. The current macd is -0.01024894.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cocrystal Pharma Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Cocrystal Pharma Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Cocrystal Pharma Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Cocrystal Pharma Inc Daily Moving Average Convergence/Divergence (MACD) ChartCocrystal Pharma Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cocrystal Pharma Inc. The current adx is 15.92.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Cocrystal Pharma Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Cocrystal Pharma Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cocrystal Pharma Inc. The current sar is 1.7209301.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Cocrystal Pharma Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cocrystal Pharma Inc. The current rsi is 48.64. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Cocrystal Pharma Inc Daily Relative Strength Index (RSI) ChartCocrystal Pharma Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cocrystal Pharma Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cocrystal Pharma Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Cocrystal Pharma Inc Daily Stochastic Oscillator ChartCocrystal Pharma Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cocrystal Pharma Inc. The current cci is -51.89747947.

Cocrystal Pharma Inc Daily Commodity Channel Index (CCI) ChartCocrystal Pharma Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cocrystal Pharma Inc. The current cmo is -3.66796469.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Cocrystal Pharma Inc Daily Chande Momentum Oscillator (CMO) ChartCocrystal Pharma Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cocrystal Pharma Inc. The current willr is -58.91805035.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Cocrystal Pharma Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Cocrystal Pharma Inc Daily Williams %R ChartCocrystal Pharma Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Cocrystal Pharma Inc.

Cocrystal Pharma Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cocrystal Pharma Inc. The current atr is 0.10712488.

Cocrystal Pharma Inc Daily Average True Range (ATR) ChartCocrystal Pharma Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cocrystal Pharma Inc. The current obv is 334,882.

Cocrystal Pharma Inc Daily On-Balance Volume (OBV) ChartCocrystal Pharma Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cocrystal Pharma Inc. The current mfi is 30.24.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Cocrystal Pharma Inc Daily Money Flow Index (MFI) ChartCocrystal Pharma Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cocrystal Pharma Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.

6.3. Candlestick Patterns

Cocrystal Pharma Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cocrystal Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.635
Ma 20Greater thanMa 501.551
Ma 50Greater thanMa 1001.540
Ma 100Greater thanMa 2001.571
OpenGreater thanClose1.480
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cocrystal Pharma Inc with someone you think should read this too:
  • Are you bullish or bearish on Cocrystal Pharma Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cocrystal Pharma Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cocrystal Pharma Inc

I send you an email if I find something interesting about Cocrystal Pharma Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Cocrystal Pharma Inc.

Receive notifications about Cocrystal Pharma Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.